NERV – Minerva Neurosciences Inc.
NERV
$4.74Name : Minerva Neurosciences, Inc
Sector : Healthcare
Industry: Biotechnology
Mark. Cap: $220,830,464.00
EPSttm : -37.03
Minerva Neurosciences, Inc
$4.74
NERV — Price & Float Short
—— Fair value
★ EPS beat
★ EPS miss
—— Target Price
Float Short %
Float Short %
3.25
Margin Of Safety %
Put/Call OI Ratio
EPS Next Q Diff
0.16
EPS Last/This Y
1.69
EPS This/Next Y
-0.6
Price
4.71
Target Price
9.5
Analyst Recom
2.33
Performance Q
-40.3
Upside
-21,631.6%
Beta
-0.13
Ticker: NERV
20 items
«
‹
of 1
›
»
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
|---|---|---|---|---|---|
| 2026-05-11 | NERV | 5.61 | N/A | N/A | 0 |
| 2026-05-12 | NERV | 5.58 | N/A | N/A | 0 |
| 2026-05-13 | NERV | 5.54 | N/A | N/A | 0 |
| 2026-05-14 | NERV | 5.47 | N/A | N/A | 0 |
| 2026-05-15 | NERV | 5.22 | N/A | N/A | 0 |
| 2026-05-18 | NERV | 4.71 | N/A | N/A | 0 |
| 2026-05-19 | NERV | 4.34 | N/A | N/A | 0 |
| 2026-05-20 | NERV | 5.04 | N/A | N/A | 0 |
| 2026-05-21 | NERV | 5.32 | N/A | N/A | 0 |
| 2026-05-22 | NERV | 5.25 | N/A | N/A | 0 |
| 2026-05-26 | NERV | 5.26 | N/A | N/A | 0 |
| 2026-05-27 | NERV | 5.26 | N/A | N/A | 0 |
| 2026-05-28 | NERV | 5 | N/A | N/A | 0 |
| 2026-05-29 | NERV | 4.93 | N/A | N/A | 0 |
| 2026-06-02 | NERV | 4.78 | N/A | N/A | 0 |
| 2026-06-03 | NERV | 4.66 | N/A | N/A | 0 |
| 2026-06-04 | NERV | 4.76 | N/A | N/A | 0 |
| 2026-06-05 | NERV | 4.97 | N/A | N/A | 0 |
| 2026-06-08 | NERV | 4.64 | N/A | N/A | 0 |
| 2026-06-09 | NERV | 4.71 | N/A | N/A | 0 |
| Date | Symbol | Latest | P/C OI | P/C Vol | Total OI |
20 items
«
‹
Current Page1 of 1
›
»
21 items
«
‹
of 1
›
»
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
|---|---|---|---|---|---|
| 2026-05-11 | NERV | 5.62 | 58.1 | - | -0.60 |
| 2026-05-12 | NERV | 5.61 | 58.1 | - | -0.60 |
| 2026-05-13 | NERV | 5.58 | 58.1 | - | -0.60 |
| 2026-05-14 | NERV | 5.48 | 58.1 | - | -0.60 |
| 2026-05-15 | NERV | 5.21 | 58.1 | - | -0.60 |
| 2026-05-18 | NERV | 4.71 | 58.1 | - | -0.60 |
| 2026-05-19 | NERV | 4.34 | 58.1 | - | -0.60 |
| 2026-05-20 | NERV | 5.05 | 58.1 | - | -0.60 |
| 2026-05-21 | NERV | 5.32 | 58.1 | - | -0.60 |
| 2026-05-22 | NERV | 5.24 | 97.7 | - | -0.20 |
| 2026-05-26 | NERV | 5.21 | 97.7 | - | -0.20 |
| 2026-05-27 | NERV | 5.26 | 97.7 | - | -0.20 |
| 2026-05-28 | NERV | 5.03 | 97.7 | - | -0.20 |
| 2026-05-29 | NERV | 4.93 | 97.7 | - | -0.20 |
| 2026-06-01 | NERV | 4.82 | 97.7 | - | -0.20 |
| 2026-06-02 | NERV | 4.76 | 97.7 | - | -0.20 |
| 2026-06-03 | NERV | 4.68 | 97.7 | - | -0.20 |
| 2026-06-04 | NERV | 4.76 | 97.7 | - | -0.20 |
| 2026-06-05 | NERV | 4.97 | 97.7 | - | -0.20 |
| 2026-06-08 | NERV | 4.66 | 97.7 | - | -0.20 |
| 2026-06-09 | NERV | 4.71 | 97.7 | - | -0.20 |
| Date | Ticker | Price | Current Quarter Growth Estimate | EBIT Estimation | Average EPS Estimate Current Year |
21 items
«
‹
Current Page1 of 1
›
»
20 items
«
‹
of 1
›
»
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
|---|---|---|---|---|
| 2026-05-11 | NERV | 0.00 | 29.81 | 3.00 |
| 2026-05-12 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-13 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-14 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-15 | NERV | 0.00 | 29.81 | 3.45 |
| 2026-05-18 | NERV | 0.00 | 15.72 | 3.44 |
| 2026-05-19 | NERV | 0.00 | 15.72 | 3.44 |
| 2026-05-20 | NERV | 0.00 | 15.72 | 3.44 |
| 2026-05-21 | NERV | 0.00 | 15.72 | 3.64 |
| 2026-05-22 | NERV | 0.00 | 15.72 | 3.64 |
| 2026-05-26 | NERV | 0.00 | 40.28 | 3.64 |
| 2026-05-27 | NERV | 0.00 | 40.28 | 3.64 |
| 2026-05-28 | NERV | 0.00 | 40.28 | 3.25 |
| 2026-05-29 | NERV | 0.00 | 40.28 | 3.25 |
| 2026-06-02 | NERV | 0.00 | 40.16 | 3.25 |
| 2026-06-03 | NERV | 0.00 | 40.16 | 3.25 |
| 2026-06-04 | NERV | 0.00 | 40.16 | 3.25 |
| 2026-06-05 | NERV | 0.00 | 40.16 | 3.25 |
| 2026-06-08 | NERV | 0.00 | 40.16 | 3.25 |
| 2026-06-09 | NERV | 0.00 | 40.16 | 3.25 |
| Date | Ticker | Insider Transactions | Institutional Transactions | Float Short |
20 items
«
‹
Current Page1 of 1
›
»
Last Quarter Act. EPS
-0.17
Avg. EPS Est. Current Quarter
-0.01
Avg. EPS Est. Next Quarter
-0.01
Insider Transactions
Institutional Transactions
40.16
Beta
-0.13
Average Sales Estimate Current Quarter
Average Sales Estimate Next Quarter
Fair Value
Quality Score
27
Growth Score
17
Sentiment Score
88
Actual DrawDown %
81.3
Max Drawdown 5-Year %
-94.5
Target Price
9.5
P/E
Forward P/E
PEG
P/S
P/B
P/Free Cash Flow
EPS
-29.16
Average EPS Est. Cur. Y
-0.2
EPS Next Y. (Est.)
-0.8
Target Price Estimates Raised
Target Price Estimates Lowered
Profit Margin
Relative Volume
0.39
Return on Equity vs Sector %
135.9
Return on Equity vs Industry %
152.1
EPS 1 7Days Diff
0.4
EPS 1 30Days Diff
0.4
EBIT Estimation
◆
NERV
Healthcare
$4.74
📉
N/A
Swing / Pullback
Buy the dip on strong trends
WEAK
Trend
0/20
Pullback
16/25
Volume
11/15
Valuation
12/20
TP/AR
5/10
Options
0/10
RSI
39.4
Range 1M
27.6%
Sup Dist
7.2%
🚀
N/A
Momentum Growth
Ride accelerating trends
WEAK
Momentum
1/25
Growth
9/30
Estimates
6/20
Inst/Vol
6/15
Options
0/10
EPS Yr
-87%
EPS NY
80.5%
52W%
29.5%
💎
N/A
Long-Term Value
Quality companies, undervalued
WEAK
🟢 BUY
+100.4% upside
Quality
3/30
Valuation
16/30
Growth
9/25
Stability
8/10
LT Trend
2/5
Upside
+100.4%
Quality
27
Click a card to see score breakdown
Full Analysis →
Sector: Healthcare
Industry: Biotechnology
Employees: 7
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone, which is in Phase 3 confirmatory trial for the treatment of negative symptoms in patients with schizophrenia. Minerva Neurosciences, Inc. was incorporated in 2007 and is based in Burlington, Massachusetts.
NERV
Latest News
—
Caricamento notizie per NERV…
stock quote shares NERV – Minerva Neurosciences Inc. Stock Price stock today
news today NERV – Minerva Neurosciences Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch NERV – Minerva Neurosciences Inc. yahoo finance google finance
stock history NERV – Minerva Neurosciences Inc. invest stock market
stock prices NERV premarket after hours
ticker NERV fair value insiders trading